Skip to content
← Back to this collection

PUBLICATIONS · 21465636

Higher dose imatinib for children with de novo chronic phase chronic myelogenous leukemia: a report from the Children's Oncology Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2011 Jul 15
First author
Champagne MA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Champagne MA
      type
      Author
    2. name
      Fu CH
      type
      Author
    3. name
      Chang M
      type
      Author
    4. name
      Chen H
      type
      Author
    5. name
      Gerbing RB
      type
      Author
    6. name
      Alonzo TA
      type
      Author
    7. name
      Cooley LD
      type
      Author
    8. name
      Heerema NA
      type
      Author
    9. name
      Oehler V
      type
      Author
    10. name
      Wood C
      type
      Author
    11. name
      French ME
      type
      Author
    12. name
      Arceci RJ
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Champagne MA
      type
      Author
    2. name
      Fu CH
      type
      Author
    3. name
      Chang M
      type
      Author
    4. name
      Chen H
      type
      Author
    5. name
      Gerbing RB
      type
      Author
    6. name
      Alonzo TA
      type
      Author
    7. name
      Cooley LD
      type
      Author
    8. name
      Heerema NA
      type
      Author
    9. name
      Oehler V
      type
      Author
    10. name
      Wood C
      type
      Author
    11. name
      French ME
      type
      Author
    12. name
      Arceci RJ
      type
      Author
    bibliography ids
    1. nci-bib-c7ee423574d7b55f59041a56
    book metadata
    content sha256
    6fd665c53109a7bcfece7a788cbffb2bb0b9d443f0c91b54492a9c61de8c80eb
    document type
    citation
    dois
    1. 10.1002/pbc.23031
    electronic publication date
    display
    2011 Apr 4
    precision
    day
    year
    2011
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:21465636
    immutable id
    pubmed:21465636@6fd665c53109a7bcfece7a788cbffb2bb0b9d443f0c91b54492a9c61de8c80eb
    journal
    abbreviation
    Pediatr Blood Cancer
    issn electronic
    1545-5017
    issn print
    1545-5009
    issue
    1
    name
    Pediatric blood & cancer
    nlm unique id
    101186624
    pages
    56-62
    volume
    57
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      21465636
      provenance
      batch id
      a366a1bc8ed89d8d7ca5
      provider
      NCBI PubMed ESummary
      record sha256
      79337be4763d87280e20fddf34682b2ca5bfe7531448e2de0112583a78e3a094
      response sha256
      c4fde29a469958f2f95ac1ef059ab1994169370e37d8293c0823efce81dabbb8
      retrieved at
      2026-09-09T23:46:40.540025+00:00
      publication date
      display
      2011 Jul 15
      precision
      day
      year
      2011
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Multicenter Study
      4. Research Support, N.I.H., Extramural
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/21465636/
      title
      Higher dose imatinib for children with de novo chronic phase chronic myelogenous leukemia: a report from the Children's Oncology Group.

      Preserved source evidence · Not medical advice